CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 8-K Event Results of operations
- 4 Open-market sale Chief Executive Officer sold 17,332 shares at an average $30.08 ($521,407)
- 8-K Event Executive or director change
- 4 Grant or award Chief Medical Officer acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Other events
- CT ORDER Other Confidential Order
- 4 Open-market sale Director sold 31,800 shares at $29.39 ($934,602)
- 4 Open-market sale Director sold 10,000 shares at $26.23 ($262,300)
- 4 Open-market sale Director sold 8,500 shares at an average $29.69 ($252,400)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 60,000 shares at an average $26.25 ($1,574,760)
- 4 Open-market sale Chief Commercial Officer sold 3,058 shares at $24.77 ($75,746)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 5,250 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 28 of 65 · 1,286 filings